title: [Adjuvant chemotherapy for stage II colon cancer].
abstract: Colorectal cancer is one of the most common diseases in China. Whether stage 11 patients should receive adjuvant chemotherapy was controversial. Here we summarize the latest advancement about clinical risk factors and biomarkers for the adjuvant chemotherapy of stage 11 colon cancer.
authors.affiliation: Department of Colorectal Surgery, Sun Yet-sen University, Guangzhou, China.
authors.forename: Yang
authors.initials: Y
authors.lastname: Zeng
authors.forename: Ping
authors.initials: P
authors.lastname: Lan
mesh_terms: D017024:Chemotherapy, Adjuvant; D002681:China; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors